Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells

Oncogene volume 33, pages 1407–1417 (2014)Cite this article

Subjects

Abstract

Serine/arginine-rich splicing factor 3 (SRSF3) likely has wide-ranging roles in gene expression and facilitation of tumor cell growth. SRSF3 knockdown induced G1 arrest and apoptosis in colon cancer cells (HCT116) in association with altered expression of 833 genes. Pathway analysis revealed ‘G1/S Checkpoint Regulation’ as the most highly enriched category in the affected genes. SRSF3 knockdown did not induce p53 or stimulate phosphorylation of p53 or histone H2A.X in wild-type HCT116 cells. Furthermore, the knockdown induced G1 arrest in p53-null HCT116 cells, suggesting that p53-dependent DNA damage responses did not mediate the G1 arrest. Real-time reverse transcription–polymerase chain reaction and western blotting confirmed that SRSF3 knockdown reduced mRNA and protein levels of cyclins (D1, D3 and E1), E2F1 and E2F7. The decreased expression of cyclin D and E2F1 likely impaired the G1-to-S-phase progression. Consequently, retinoblastoma protein remained hypophosphorylated in SRSF3 knockdown cells. The knockdown also induced apoptosis in association with reduction of BCL2 protein levels. We also found that SRSF3 knockdown facilitated skipping of 81 5′-nucleotides (27 amino acids) from exon 8 of homeodomain-interacting protein kinase-2 (HIPK2) and produced a HIPK2 Δe8 isoform. Full-length HIPK2 (HIPK2 FL) is constantly degraded through association with an E3 ubiquitin ligase (Siah-1), whereas HIPK2 Δe8, lacking the 27 amino acids, lost Siah-1-binding ability and became resistant to proteasome digestion. Interestingly, selective knockdown of HIPK2 FL induced apoptosis in various colon cancer cells expressing wild-type or mutated p53. Thus, these findings disclose an important role of SRSF3 in the regulation of the G1-to-S-phase progression and alternative splicing of HIPK2 in tumor growth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Manley JL, Krainer AR . A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev 2010; 24: 1073–1074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chen M, Manley JL . Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10: 741–754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lin S, Coutinho-Mansfield G, Wang D, Pandit S, Fu X-D . The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 2008; 15: 819–826.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lou H, Neugebauer KM, Gagel RF, Berget SM . Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 1998; 18: 4977–4985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sapra AK, Anko ML, Grishina I, Lorenz M, Pabis M, Poser I et al. SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. Mol Cell 2009; 34: 179–190.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang Z, Krainer AR . Involvement of SR proteins in mRNA surveillance. Mol Cell 2004; 16: 597–607.

    Article  CAS  PubMed  Google Scholar 

  7. Sanford JR, Gray NK, Beckmann K, Caceres JF . A novel role for shuttling SR proteins in mRNA translation. Genes Dev 2004; 18: 755–768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Anczuków O, Rosenberg AZ, Akerman M, Das S, Zhan L, Karni R et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 2012; 19: 220–228.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G . Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 1998; 58: 5818–5824.

    CAS  PubMed  Google Scholar 

  10. Ahn E-Y, DeKelver Russell C, Lo M-C, Nguyen Tuyet A, Matsuura S, Boyapati A et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell 2011; 42: 185–198.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Li X, Manley JL . Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005; 122: 365–378.

    Article  CAS  PubMed  Google Scholar 

  12. Li X, Wang J, Manley JL . Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev 2005; 19: 2705–2714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xiao R, Sun Y, Ding J, Lin S, Rose D, Rosenfeld M et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol 2007; 27: 5393–5402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Moore MJ, Wang Q, Kennedy CJ, Silver PA . An alternative splicing network links cell-cycle control to apoptosis. Cell 2010; 142: 625–636.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Srebrow A, Kornblihtt A . The connection between splicing and cancer. J Cell Sci 2006; 119: 2635–2641.

    Article  CAS  PubMed  Google Scholar 

  16. He X, Ee P, Coon J, Beck W . Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res 2004; 10: 4652–4660.

    Article  CAS  PubMed  Google Scholar 

  17. He X, Arslan AD, Pool MD, Ho TT, Darcy KM, Coon JS et al. Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene 2011; 30: 356–365.

    Article  CAS  PubMed  Google Scholar 

  18. Stickeler E, Kittrell F, Medina D, Berget SM . Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999; 18: 3574–3582.

    Article  CAS  PubMed  Google Scholar 

  19. Jumaa H, Wei G, Nielsen PJ . Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol 1999; 9: 899–902.

    Article  CAS  PubMed  Google Scholar 

  20. Änkö ML, Morales L, Henry I, Beyer A, Neugebauer KM . Global analysis reveals SRp20- and SRp75-specific mRNPs in cycling and neural cells. Nat Struct Mol Biol 2010; 17: 962–970.

    Article  PubMed  Google Scholar 

  21. Hailemariam K, Iwasaki K, Huang BW, Sakamoto K, Tsuji Y . Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress. J Cell Sci 2010; 123: 3863–3871.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4: 1–10.

    Article  CAS  PubMed  Google Scholar 

  23. D’Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11–19.

    Article  PubMed  Google Scholar 

  24. Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J et al. HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 13040–13045.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008; 10: 812–824.

    Article  CAS  PubMed  Google Scholar 

  26. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739–750.

    Article  CAS  PubMed  Google Scholar 

  27. Choi DW, Seo YM, Kim EA, Sung KS, Ahn JW, Park SJ et al. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 2008; 283: 4682–4689.

    Article  CAS  PubMed  Google Scholar 

  28. Calzado MA, de la Vega L, Moller A, Bowtell DD, Schmitz ML . An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol 2009; 11: 85–91.

    Article  CAS  PubMed  Google Scholar 

  29. Kim SY, Choi DW, Kim EA, Choi CY . Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett 2009; 279: 177–184.

    Article  CAS  PubMed  Google Scholar 

  30. Sombroek D, Hofmann TG . How cells switch HIPK2 on and off. Cell Death Differ 2009; 16: 187–194.

    Article  CAS  PubMed  Google Scholar 

  31. Puca R, Nardinocchi L, Givol D, D’Orazi G . Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 2010; 29: 4378–4387.

    Article  CAS  PubMed  Google Scholar 

  32. Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD . SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 2009; 35: 1–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, Macfarlan T et al. Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation. Mol Cell 2009; 33: 450–461.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Schwerk C, Schulze-Osthoff K . Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 2005; 19: 1–13.

    Article  CAS  PubMed  Google Scholar 

  35. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y . Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998; 273: 25875–25879.

    Article  CAS  PubMed  Google Scholar 

  36. Giraud S, Diaz-Latoud C, Hacot S, Textoris J, Bourette RP, Diaz JJ . US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest. J Virol 2004; 78: 2984–2993.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH . Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003; 115: 177–186.

    Article  CAS  PubMed  Google Scholar 

  38. Hofmann TG, Stollberg N, Schmitz ML, Will H . HIPK2 regulates transforming growth factor-beta-induced c-Jun NH2-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003; 63: 8271–8277.

    CAS  PubMed  Google Scholar 

  39. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML et al. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 2006; 25: 3955–3965.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hikasa H, Ezan J, Itoh K, Li X, Klymkowsky MW, Sokol SY . Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification. Dev Cell 2010; 19: 521–532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M et al. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene 2011; 30: 4802–4813.

    Article  CAS  PubMed  Google Scholar 

  42. D’Orazi G, Rinaldo C, Soddu S . Updates on HIPK2: a resourceful oncosuppressor for clearing cancer. J Exp Clin Cancer Res 2012; 31: 63.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Kuwano Y, Kamio Y, Kawai T, Katsuura S, Inada N, Takaki A et al. Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS One 2011; 6: e24723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kurokawa K, Kuwano Y, Tominaga K, Kawai T, Katsuura S, Yamagishi N et al. Brief naturalistic stress induces an alternative splice variant of SMG-1 lacking exon 63 in peripheral leukocytes. Neurosci Lett 2010; 484: 128–132.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to KR).

Author information

Authors and Affiliations

  1. Department of Stress Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan

    K Kurokawa, Y Akaike, K Masuda, Y Kuwano, K Nishida, N Yamagishi, K Kajita, T Tanahashi & K Rokutan

Authors
  1. K Kurokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Akaike
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Kuwano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Yamagishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Kajita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Tanahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Rokutan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Kurokawa.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurokawa, K., Akaike, Y., Masuda, K. et al. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells. Oncogene 33, 1407–1417 (2014). https://doi.org/10.1038/onc.2013.86

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2013.86

Keywords

This article is cited by

Search

Advanced search

Quick links